ArticleBiomedicines2022

Epigenetic Effects of Gender-Affirming Hormone Treatment: A Pilot Study of the ESR2 Promoter's Methylation in AFAB People.

Francesco Pallotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.